资本运作持续发力，广药资本在管基金认缴规模47亿元，实缴24亿元，将重点投向创新药、高端医疗器械等前沿领域；科 技创新强化核心引擎，布局近20项在研新药，今年新增26个新产品项目；国际拓展迈入新阶段，持续开拓东南亚、中东、南美 市场。 作为本次研讨会的核心亮点之一，广药集团正式揭晓核医疗产业布局及广州白云山稀核健康医药有限公司创新成果。与此 同时，白云山稀核健康与全球医疗科技巨头GE医疗签署战略合作协议，以跨界协同赋能核医疗产业高质量发展。 广药集团党委书记、董事长李小军在欢迎辞中表示，广药集团长期稳健发展与产业链上下游伙伴的精诚协作密不可分。当 前，面对医药健康行业新变化，广药集团正锚定"现代化、数字化、科技化、国际化"战略方向，全力推进"十五五"规划，向 着"再造一个新广药"的目标加速迈进，并取得多方面进展。 （编辑 李家琪 郭之宸） 会上，广药集团联合国家药监局南方医药经济研究所共同发起的"中国创新药研发与产业发展研究报告项目"正式启动。这 一举措将有效整合产业链上下游资源，推动破解创新药研发"卡脖子"难题，助力我国从制药大国向制药强国跨越。 本报讯 （记者王镜茹）11月18日，2025年广州医药集团有 ...

Core Insights - The "World Fusion Energy Group" held its second ministerial meeting and the 30th International Conference on Fusion Energy in Chengdu, where Sichuan province announced 24 policy measures to promote the high-quality development of the nuclear medicine industry [1][12] - Chengdu is positioning itself as a leader in the nuclear medicine sector, focusing on the entire industry chain from the production of medical isotopes to the development of radiopharmaceuticals and manufacturing of nuclear medical equipment [3][6] Policy Measures - Sichuan's new policies aim to support precise targeting, industrial upgrades, expanding application demands, and creating a favorable development environment [1] - The release of an opportunity list in the nuclear medicine sector highlights Chengdu's commitment to developing three nuclear drug bases [1] Industry Developments - Chengdu's nuclear medicine sector has seen significant advancements, including the clinical approval of innovative nuclear drugs and substantial financing for nuclear medicine companies [3][4][12] - The establishment of the Fosun Pharma nuclear drug platform in Chengdu marks a strategic move to enhance research and development in the nuclear medicine field [9][10] Innovation and Breakthroughs - Chengdu's Baile Tianheng received approval for its first antibody-radiolabeled drug, which is expected to significantly improve treatment for advanced or metastatic solid tumors [4] - The successful development and export of a domestically produced germanium-gallium generator by Chengdu's Nureter Medical Technology represents a breakthrough in the self-sufficiency of medical isotopes [5] Ecosystem and Collaboration - Chengdu is fostering a collaborative ecosystem that integrates policy support, capital investment, talent attraction, and industry-academia cooperation to enhance the nuclear medicine industry [12][13] - The establishment of specialized parks and research centers in Chengdu is aimed at creating a comprehensive support system for nuclear medicine innovation [11][14]

Core Viewpoint - The Guangdong Provincial Development and Reform Commission has issued an action plan to accelerate the high-quality development of the nuclear medicine industry from 2025 to 2030, aiming for significant improvements in innovation capabilities, key technology breakthroughs, and the establishment of a competitive nuclear medicine industry cluster by 2030 [1][3]. Industry Development - The nuclear medicine industry is experiencing unprecedented growth opportunities due to global aging populations, rising chronic disease rates, and continuous technological innovations [2]. - Recent favorable policies at both national and local levels are propelling the rapid development of the nuclear medicine industry in China, with a focus on enhancing innovation capabilities and expanding application fields [3]. Market Size - According to a report by Zhongyan Puhua Industry Research Institute, the global nuclear medicine market is expected to exceed $100 billion by 2025, with a compound annual growth rate of over 10%, potentially reaching over $200 billion by 2030 [4]. Company Developments - Companies in the nuclear medicine sector are actively advancing their positions, with Shanghai United Imaging Healthcare Co., Ltd. recently obtaining a patent for a scanning method for nuclear medicine devices [5]. - Qingdao Baiyang Pharmaceutical Co., Ltd. announced that its radiopharmaceutical, a first-class new drug in China, has successfully met key clinical trial endpoints, addressing significant challenges in tumor imaging diagnostics [5]. Challenges - The nuclear medicine field faces challenges due to high technical barriers and strict regulatory policies, requiring substantial investment in research and development to overcome technological bottlenecks [6]. - Market awareness of nuclear medicine products is relatively low, and the high costs associated with these technologies pose additional challenges for widespread adoption [6].

Economic Performance - In May, the national economy showed stable growth with industrial production increasing by 5.8% year-on-year, and equipment manufacturing and high-tech manufacturing growing by 9% and 8.6% respectively, outpacing the overall industrial growth by 3.2 and 2.8 percentage points [1] - The service sector's production index rose by 6.2% year-on-year in May, with significant contributions from information transmission, software, and IT services (11.2%), leasing and business services (8.9%), and wholesale and retail (8.4%) [1] - Retail sales saw a notable recovery, with total retail sales of consumer goods reaching 41,326 billion yuan, a year-on-year increase of 6.4%, accelerating by 1.3 percentage points from the previous month [1] Employment and Prices - The urban survey unemployment rate in May was 5%, a decrease of 0.1 percentage points from the previous month, indicating overall employment stability [2] - The Consumer Price Index (CPI) fell by 0.1% year-on-year and 0.2% month-on-month, while the core CPI, excluding food and energy, increased by 0.6% year-on-year, reflecting a slight acceleration in inflation [2] Investment and Trade - Fixed asset investment (excluding rural households) from January to May totaled 191,947 billion yuan, growing by 3.7% year-on-year, with a notable 7.7% growth when excluding real estate development investment [1] - The total value of goods imports and exports in May reached 38,098 billion yuan, with exports increasing by 6.3% and imports decreasing by 2.1% [1] Corporate Developments - GAC Aion faced employee stock valuation issues, with employees potentially recovering only 42% of their investments due to significant devaluation [5] - Tencent launched an algorithm competition with substantial rewards to attract global talent, supporting its recruitment efforts and enhancing its machine learning capabilities [5] - Xiaomi's automotive factory achieved a production capacity of 20,000 to 30,000 vehicles per month, showcasing high levels of automation [6] - Gree Titanium New Energy announced a court-ordered freeze on its 100% stake in Zhuhai Guangtong Automobile, stemming from past management issues, but stated that operations remain unaffected [6] International Developments - The U.S. Department of Justice is reviewing Alphabet's proposed $32 billion acquisition of cybersecurity startup Wiz for potential antitrust concerns [8] - Santos received a non-binding acquisition offer from a consortium led by Abu Dhabi National Oil Company, valuing the company at $18.7 billion [8] - MicroStrategy announced the purchase of 10,100 bitcoins for approximately $1.05 billion, bringing its total holdings to 592,100 bitcoins [9]